Susquehanna International Group, LLP Day One Biopharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 64,661 shares of DAWN stock, worth $860,637. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,661
Previous 91,098
29.02%
Holding current value
$860,637
Previous $1.26 Million
28.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
84MCall Options Held
144KPut Options Held
218K-
Ra Capital Management, L.P. Boston, MA7.87MShares$105 Million1.53% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$85.6 Million11.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$78.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$64.9 Million1.92% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$60.3 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $978M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...